title: [Facial palsy sequel and botulinum toxin].
abstract: Medical treatment of facial paralysis sequel is an essential part of the overall management of this pathology. The use of botulinum toxin has revolutionized results in greatly improving facial symmetry. The toxin can be used either the healthy side of the face by treating the compensatory hyperactivity of non-paralyzed side of the face or the paralyzed side (in the spastic forms) to treat synkinesis and spasms of the face on the pathologic side. This treatment course will be complemented by the rest of the therapeutic, i.e. rehabilitation and surgical treatment.
authors.affiliation: Service de chirurgie maxillofaciale, hôpital Paris Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France. Electronic address: lbenichou@hpsj.fr.
authors.forename: L
authors.initials: L
authors.lastname: Benichou
authors.affiliation: 4, place Fontette, 14000 Caen, France.
authors.forename: D
authors.initials: D
authors.lastname: Labbe
authors.affiliation: 59, rue Spontini, 75116 Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Le Louarn
authors.affiliation: Service de chirurgie plastique, reconstructrice et esthétique, CHRU de Lille, 2, avenue Oscar-Lambret, 59000 Lille, France.
authors.forename: P
authors.initials: P
authors.lastname: Guerreschi
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005158:Facial Paralysis / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000627:therapeutic use*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
keywords: Botulinum toxin; Co-contraction; Facial paralysis; Hyperactivity; Hyperactivité; Paralysie faciale; Spasm; Spasme; Syncinésie; Synkinesis; Toxine botulique; Traitement; Treatment